This Analyst Boosts Price Target On Satsuma Pharmaceuticals By 200%? Plus UBS Predicts $38 For General Motors

This Analyst Boosts Price Target On Satsuma Pharmaceuticals By 200%? Plus UBS Predicts $38 For General Motors
  • SVB Leerink raised the price target on Satsuma Pharmaceuticals, Inc. STSA from $5 to $15. SVB Leerink analyst Marc Goodman upgraded the stock from Market Perform to Outperform. Satsuma Pharmaceuticals shares fell 3.8% to close at $5.36 on Friday.
  • UBS cut the price target for General Motors Company GM from $56 to $38. UBS analyst Patrick Hummel downgraded the stock from Buy to Neutral. GM shares fell 3.2% to $32.55 in pre-market trading.
  • JMP Securities cut the price target on Terreno Realty Corporation TRNO from $75 to $69. Terreno Realty shares fell 3.2% to close at $51.26 on Friday.
  • Barclays cut the price target for Turning Point Brands, Inc. TPB from $28 to $22. Turning Point Brands shares fell 1.9% to $20.83 in pre-market trading.
  • Keybanc cut the price target for Ventas, Inc. VTR from $60 to $56. Ventas shares fell 1.6% to close at $37.72 on Friday.
  • Mizuho lowered the price target on The Sherwin-Williams Company SHW from $288 to $264. Sherwin-Williams shares fell 5.2% to close at $205.60 on Friday.
  • Jefferies slashed the price target on Lincoln National Corporation LNC from $55 to $51. Lincoln National shares fell 0.2% to $46.70 in pre-market trading.

Check out this: Ford, General Motors And Some Other Big Stocks Moving Lower In Today's Pre-Market Session

Don’t forget to check out our premarket coverage here .

Posted In: FinancialsLife & Health InsurancePT ChangesNewsPrice TargetSmall CapPre-Market OutlookMarketsAnalyst RatingsTrading Ideas